Here are five things to know:
1. The orthopedic device company also filed an automatic shelf registration statement related to the public offering of ordinary shares, which was originally filed May 4, 2016.
2. The public offering’s net proceeds are expected to hit $423 million.
3. Securities are offered by means of a written prospectus.
4. J.P. Morgan is the sole underwriter for this offering.
5. Yesterday, the company reported an agreement to acquire Cartiva, a private orthopedic medical device company focused on treatment for osteoarthritis of the great toe, for $435 million. The company expects full-year 2018 Cartiva revenues to hit $35 million, a 50 percent growth over last year.
More articles on orthopedic devices:
Wright Medical to buy orthopedic manufacturer for $435M: 5 notes
Jury awards $8.2M in patent infringement suit against DePuy Synthes: 5 things to know
K2M generates $73.6M in Q2 revenue: 5 financial report details
